GENE ONLINE|News &
Opinion
Blog

FDA
Fake Ozempic Floods Market as FDA Warns Patients to Check Authenticity of Prescriptions
2025-04-16
Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part II
2025-04-01
Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part I
2025-03-31
FDA Leadership Change Raises Concerns Among Biopharma Industry Over Future Collaboration
2025-03-30
Peter Marks Steps Down as Head of FDA’s CBER Amid Industry Concerns
2025-03-30
FDA Greenlights Soleno Therapeutics’ VYKAT XR for PWS Hyperphagia
2025-03-28
Sanofi Secures FDA Fast Track Designation for its Chlamydia Prevention mRNA Vaccine
2025-03-27
FDA Proposes Restrictions on Bulk Production of Copycat Weight Loss Drugs Amid Industry Pushback
2025-03-21
Merck Faces Patent Battle with Halozyme Over Latest Keytruda Injection
2025-03-09
Novo Nordisk Takes on Eli Lilly in Weight Loss Drug Battle with Wegovy Price Cut
2025-03-06
Lilly Slashes Zepbound Vial Prices by Up to 50% to Expand Access for Uninsured Patients
2025-02-26
GSK’s Penmenvy Secures FDA Approval to Combat Five Major Meningococcal Serogroups Among Youth
2025-02-17
Major Win – FDA Grants Fast Track Designation to Adicet Bio’s ADI-001 for Lupus Disease
2025-02-07
Easing the Mental Health Burden: How MDMA, Psilocybin, and Other Psychedelics May Open Doors for Treating PTSD, Addiction, and Autism
2025-01-28
Drug Promotion, Nonprescription Pathways, and Advanced Manufacturing: FDA’s Key Focus Areas in 2024 and What’s Next for 2025
2025-01-23
1 2 3 26
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top